标题
Challenges and exploration for immunotherapies targeting cold colorectal cancer
作者
关键词
-
出版物
World Journal of Gastrointestinal Oncology
Volume 15, Issue 1, Pages 55-68
出版商
Baishideng Publishing Group Inc.
发表日期
2023-01-09
DOI
10.4251/wjgo.v15.i1.55
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy of radiotherapy combined with immune checkpoint inhibitors in patients with melanoma
- (2022) Gaofei Yin et al. MELANOMA RESEARCH
- Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
- (2022) Cong Liu et al. Frontiers in Cell and Developmental Biology
- Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis
- (2022) Yuegang Li et al. BMC GASTROENTEROLOGY
- Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer
- (2022) Tugba Akin Telli et al. CANCER TREATMENT REVIEWS
- MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF metastatic colorectal cancer
- (2022) J. Tabernero et al. ESMO Open
- Regorafenib-Avelumab combination in patients with microsatellite stable colorectal cancer (REGOMUNE) : a single arm, open-label, phase II trial
- (2021) Sophie Cousin et al. CLINICAL CANCER RESEARCH
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
- (2021) N.E. Donlon et al. CANCER LETTERS
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes
- (2021) Alexander Malogolovkin et al. Viruses-Basel
- Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy
- (2021) Fusheng Zhang et al. CANCER LETTERS
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
- (2020) Shota Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis
- (2020) Keywan Mortezaee LIFE SCIENCES
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer
- (2020) Eric X. Chen et al. JAMA Oncology
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity
- (2020) Wenjing Yang et al. Nature Communications
- The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
- (2020) Taiki Hakozaki et al. Cancer Immunology Research
- Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment
- (2020) Yang Zhao et al. Acta Pharmaceutica Sinica B
- Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives
- (2020) Aja Badgeley et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside
- (2020) Darleny Y. Lizardo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer
- (2019) Huawei Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
- (2019) John D. Martin et al. Annual Review of Physiology
- Oncolytic Viruses: Priming Time for Cancer Immunotherapy
- (2019) Luke Russell et al. BIODRUGS
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
- (2019) Shinichi Yachida et al. NATURE MEDICINE
- Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy
- (2019) Aaron M. Goodman et al. Cancer Immunology Research
- Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
- (2019) François Ghiringhelli et al. Frontiers in Immunology
- Interactions between Intestinal Microflora/Probiotics and the Immune System
- (2019) Chen-xing Zhang et al. Biomed Research International
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- (2018) Frederick Arce Vargas et al. CANCER CELL
- Checkpoint inhibitors as treatment for malignant gliomas: “A long way to the top”
- (2018) Matteo Simonelli et al. CANCER TREATMENT REVIEWS
- Hypoxia and acidosis: immune suppressors and therapeutic targets
- (2018) Sultan Damgaci et al. IMMUNOLOGY
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Targeting VEGF/VEGFR to Modulate Antitumor Immunity
- (2018) Ju Yang et al. Frontiers in Immunology
- Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
- (2018) Qiang Wang et al. CANCER LETTERS
- Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
- (2018) Christian U. Blank et al. NATURE MEDICINE
- Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring aPOLEMutation
- (2017) Jun Gong et al. Journal of the National Comprehensive Cancer Network
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- DNA Damage and Repair Biomarkers of Immunotherapy Response
- (2017) Kent W. Mouw et al. Cancer Discovery
- Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance
- (2017) Sean McNabney et al. Nutrients
- The Immune System's Contribution to the Clinical Efficacy of EGFR Antagonist Treatment
- (2017) Felicity MacDonald et al. Frontiers in Pharmacology
- Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
- (2016) J. M. Kim et al. ANNALS OF ONCOLOGY
- Tumor antigens in human cancer control
- (2016) Sander Kelderman et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
- (2016) Jacques Bernier CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
- (2016) Frank A. Schildberg et al. IMMUNITY
- Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody
- (2016) Sherri Dudal et al. JOURNAL OF IMMUNOTHERAPY
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
- (2016) P. Baumgaertner et al. OncoImmunology
- Immunogenic cell death
- (2015) Abhishek D. Garg et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade
- (2015) Elizabeth Buchbinder et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut Microbiome
- (2015) Gail A. Cresci et al. NUTRITION IN CLINICAL PRACTICE
- Radiotherapy and Immunogenic Cell Death
- (2015) Encouse B. Golden et al. SEMINARS IN RADIATION ONCOLOGY
- The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy
- (2015) Yanping Xiao et al. Cancer Discovery
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery
- (2015) Celeste B. Greer et al. Cell Reports
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
- (2014) Shoichi Hazama et al. Journal of Translational Medicine
- High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine
- (2014) Takuro Saito et al. VACCINE
- Measurement of serum antibodies against NY-ESO-1 by ELISA: A guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer
- (2014) YAN-YAN LONG et al. Experimental and Therapeutic Medicine
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Human Gut Microbiome and Risk for Colorectal Cancer
- (2013) Jiyoung Ahn et al. JNCI-Journal of the National Cancer Institute
- Uropod elongation is a common final step in leukocyte extravasation through inflamed vessels
- (2012) Young-Min Hyun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor Immunotherapy Directed at PD-1
- (2012) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer
- (2011) Francesco Bertolini et al. DRUG DISCOVERY TODAY
- Tumors as Organs: Complex Tissues that Interface with the Entire Organism
- (2010) Mikala Egeblad et al. DEVELOPMENTAL CELL
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
- (2008) T. Schulze et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clearance of influenza virus from the lung depends on migratory langerin+CD11b−but not plasmacytoid dendritic cells
- (2008) Corine H. GeurtsvanKessel et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started